Lallemand Pharma

News details

Dec
12,
2016

A good clinical outcome following therapy with a polyvalent mechanical bacterial lysate (PMBL) correlates with the capacity of inducing a specific locoregional immunoresponse in patients with recurrent upper respiratory tract infections

Dec 12, 2016